FierceBiotech Reveals the Fierce 15 Winners of 2017

Share Article

FierceBiotech has unveiled its annual Fierce 15 list of up-and-coming biotech companies expected to make big waves in the industry.

The final fifteen companies are chosen from hundreds of nominations submitted by readers and editors of FierceBiotech, a publication from Questex, LLC.

“The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the best and brightest management teams," FierceBiotech editor Ben Adams said, "and we want to see that the promise they hold in their hands has—in this industry built on the all or nothing of risk and reward—a genuine chance of being the Next Big Thing.”

The Fierce 15 highlights privately held companies that are working to develop innovative products, services, or platforms that can advance the biotech industry and transform patient treatment.

“This year’s crop is the best-funded we’ve seen, and speaks volumes about the rude health of early-stage biomedical research this year,” Adams continued. “When we look at the science, the teams, and talk to their leaders, the key issue is the future: In the next five to ten years, will their product or platform produce something revolutionary and game-changing, and does it have a shot of becoming the new standard of therapy in its respective area.”

Below are the fifteen companies FierceBiotech predicts will shape the industry for years to come:

  •     Rubius Therapeutics
  •     Vividion Therapeutics
  •     Vir Biotechnology
  •     Axial Biotherapeutics
  •     Turnstone Biologics
  •     PMV Pharma
  •     Gritstone Oncology
  •     Tango Therapeutics
  •     Repare Therapeutics
  •     Magenta Therapeutics
  •     Vivet Therapeutics
  •     PsiOxus Therapeutics
  •     Aravive Biologics
  •     Relay Therapeutics
  •     BlackThorn Therapeutics

For company profiles and more information on the Fierce 15, visit the FierceBiotech special report: http://www.fiercebiotech.com/special-report/fiercebiotech-s-2017-fierce-15.

FierceBiotech is an internationally recognized online publication and email newsletter focusing on the latest news, trends, and analysis within the biotechnology industry.

About Questex

Questex is a leading global business information and events company serving corporate and government clients and industries that are driving economic growth and business innovation around the world.

The company drives business investment, innovation and demand-creation in the markets it serves by bringing together investors, buyers, sellers and professionals through its over 100 trade shows, conferences and other business events, informing them through more than 100 business media and information products and supporting clients with a comprehensive platform of marketing solutions. Questex’s industry-focused marketplaces include Life Sciences & Healthcare, Hospitality & Travel, Beauty & Wellness, Technology & Telecommunications groups.

Questex is headquartered in Newton, Massachusetts. The company employs over 350 dedicated professional staff members, who are located in offices throughout the United States, Europe and the Asia-Pacific region.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Eloise Mansfield
Questex
+1 2028245096
Email >
Visit website